{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01939",
      "entity_text" : "p53-TAD",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P03732",
      "entity_text" : "GPU",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Here, we combined the highly accurate atomistic force field a99SB-disp 48, enhanced sampling technique replica exchange with solute tempering (REST2) XREF_BIBR - XREF_BIBR, and GPU accelerated MD simulations to investigate how four cancer associated mutations, K24N, N29K / N30D, D49Y, and W53G, and binding of an anti-cancer drug, epigallocatechin gallate (EGCG) (XREF_FIG), may modulate the disordered ensemble of p53-TAD.",
  "reading_complete" : "2020-08-08T11:10:06Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T11:08:54Z",
  "trigger" : "accelerated",
  "evidence" : [ "GPU-accelerated MD simulations to investigate how four cancer-associated mutations, K24N, N29K/N30D, D49Y, and W53G, and binding of an anti-cancer drug, epigallocatechin gallate (EGCG) ( XREF_FIG ), may modulate the disordered ensemble of p53-TAD" ],
  "pmc_id" : "6934143",
  "score" : 0
}